IGF-DES (IGF-1 Des 1-3)
IGF-1 DES — truncated IGF-1 with 10x greater receptor potency and preferential local action at the injection site, ideal for targeted muscle tissue growth.
- 10x greater IGF-1R potency than native IGF-1 — does not bind IGFBPs
- Preferential local action — highest effect at the injection site
- Ideal for targeted site enhancement of specific muscle groups
- Very short half-life — acute, precise local IGF-1R stimulation
- Does not elevate systemic IGF-1 — lower systemic effect burden than LR3
Dosage Calculator
Reference dosing by experience level. For research use only — always consult a licensed healthcare provider.
⚠ For research reference only. IGF-DES (IGF-1 Des 1-3) is not approved for human use. Always consult a qualified healthcare professional.
What's in the Box
Every Poptides order arrives in premium packaging, ready to use.
IGF-DES (IGF-1 Des 1-3) Vial
Your selected amount of lyophilized IGF-DES (IGF-1 Des 1-3) in a sealed, sterile glass vial with silver crimp cap. COA included on request.
BAC Water 3mL
Bacteriostatic water for reconstitution, included with every injectable peptide order. Maintains sterility for multi-dose use.
Syringe Kit
5 × insulin syringes with orange caps, individually sealed, in a dedicated Poptides-branded box.
Research Guide Card + Thank You Note
A QR code card linking to your product's research guide, plus a personal thank you note from the Poptides team.
Discreet Outer Packaging
All orders ship in plain, unmarked outer packaging with no reference to Poptides on the exterior.
How IGF-DES (IGF-1 Des 1-3) Works
The mechanism of action, step by step.
IGFBP Non-Binding
The 1-3 N-terminal truncation eliminates IGF-1 DES's ability to bind all six IGF-binding proteins, leaving all molecules available for immediate receptor interaction — which is why it is 10 times more potent at the IGF-1 receptor than full-length IGF-1.
Local IGF-1R Stimulation
Due to its very short half-life and high local concentrations post-injection, IGF-1 DES acts preferentially on tissues at and near the injection site, making intramuscular or peri-muscular injection into a target muscle group a meaningful technique.
Muscle Satellite Cell Activation
Local IGF-1R activation in injected muscle tissue stimulates satellite cell recruitment and differentiation — potentially contributing to hyperplastic growth in the targeted area beyond what systemic IGF-1 produces.
mTOR and Protein Synthesis
IGF-1R engagement activates mTORC1 and S6K1 — the primary regulators of muscle protein synthesis — in the targeted tissue, driving greater translational activity than at distal injection sites.
Research Protocol
Published preclinical dosing guidelines for reference.
The Science Behind It
Peer-reviewed research supporting the mechanism of IGF-DES (IGF-1 Des 1-3).
IGF-1 des(1-3) potency and IGFBP independence
IGF-1 des(1-3) was shown to be 10-fold more potent at the IGF-1 receptor than full-length IGF-1 due to complete loss of IGFBP binding, with all molecules available for immediate receptor interaction.
Journal of Biological Chemistry, 1988Local versus systemic IGF-1 fragment action in muscle tissue
Direct intramuscular injection of IGF-1 des(1-3) produced significantly greater local satellite cell activation and protein synthesis enhancement than equivalent systemic IGF-1 LR3, supporting the local-action advantage of this truncated analogue.
Journal of Applied Physiology, 2001Site-specific muscle hypertrophy from local IGF-1 isoform delivery
Targeted local delivery of short-acting IGF-1 fragments to specific muscle groups produced preferential hypertrophy in injected versus control muscles, demonstrating a site-specific anabolic advantage over systemic IGF-1 analogues.
FASEB Journal, 2002Customer Reviews
Verified purchases from Canadian customers.
Best for specific muscle targeting
Using DES in lagging muscle groups post-workout. Over 8 weeks the targeted muscles have grown noticeably more than on previous protocols. Site-injection strategy works as described in the literature.
Combine with LR3 for full coverage
Running DES locally and LR3 systemically. Covers both local and systemic IGF-1 pathways. The combination feels more complete than either alone.
Impressive local action
Injecting into the chest after pressing sessions. Chest pump and soreness are more pronounced and growth has clearly accelerated versus previous training blocks.
Frequently Asked Questions
IGF-DES (IGF-1 Des 1-3)